LiveCast: Market News on Screen and Read Aloud
Follow chronological market-moving headlines with impact filters, ticker tags, duplicate grouping and an opt-in audio squawk during scheduled coverage.
MergerBrief Daily: Deal News ARGX/FBRX: argenx to Acquire Forte Biosciences, Inc., Adding First-in-Class anti-CD122 Antibody, FB102, to its
ARGX.FBRXFBRFHITCBKFHI.ENEE.DNEEEQUI